We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Oxygen Device for Premature Babies

By HospiMedica staff writers
Posted on 08 Jan 2004
A compact and inexpensive device has been developed for use in developing countries to provide oxygen and atmospheric air to premature babies suffering from respiratory problems.

Called Oxymix, the device ensures the appropriate air/oxygen mix by supplying the correct flow rate of any concentration of oxygen, from 21-100%, from a single 100% oxygen gas supply. More...
Hospitals in many developing countries have access to medical-grade compressed oxygen but not to medical-grade compressed air. In such hospitals, babies with respiratory difficulties are often put in an oxygen hood, which is supplied with a small amount of pure oxygen. However, the build-up of the baby's exhaled carbon dioxide can cause serious problems, Also, the level of oxygen is hard to maintain. If it is too high, it can cause blindness, but if it is too low, it can cause brain damage.

In modern hospitals, the alternative products are either a very expensive air/oxygen blender or a noisy high gas-flow mixer. Oxymix will be available for about one-fourth the cost of a blender. The device is the result of a joint effort between the Australian medical device company NASCOR (Sydney) and CSIRO BioMedical Devices (Sydney). CSIRO is the Commonwealth Scientific and Industrial Research Organization of Australia.

"NASCOR went to CSIRO to help us develop this device because we knew of their expertise in gas flow and turbine technology,” said Dr. Howard Chilton, chairman of R&D at NASCOR. "CSIRO's mechanical design met all of our objectives in a most elegant fashion.”




Related Links:
NASCOR
CSIRO

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.